TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy (Q42145160)

17 October 2017

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy (English)

1 reference

17 October 2017

Jaya M Satagopan

3

0 references

Hikmat Al-Ahmadie

object named as

Hikmat A Al-Ahmadie

5

0 references

author name string

Anuradha Gopalan

1

1 reference

17 October 2017

Margaret A Leversha

2

1 reference

17 October 2017

Qin Zhou

4

1 reference

17 October 2017

Samson W Fine

6

1 reference

17 October 2017

James A Eastham

7

1 reference

17 October 2017

Peter T Scardino

8

1 reference

17 October 2017

Howard I Scher

9

1 reference

17 October 2017

Satish K Tickoo

10

1 reference

17 October 2017

Victor E Reuter

11

1 reference

17 October 2017

William L Gerald

12

1 reference

17 October 2017

language of work or name

English

0 references

publication date

3 February 2009

1 reference

17 October 2017

1 reference

17 October 2017

69

1 reference

17 October 2017

4

1 reference

17 October 2017

1400-1406

1 reference

The role of SPINK1 in ETS rearrangement-negative prostate cancers

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Long-term outcome among men with conservatively treated localised prostate cancer.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Radical prostatectomy versus watchful waiting in early prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Gene expression profiling predicts clinical outcome of prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

The polycomb group protein EZH2 is involved in progression of prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Delineation of prognostic biomarkers in prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Mapping of genomic clones by fluorescence in situ hybridization

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3676271

Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker

1 December 2018

1 reference

12 December 2020

Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry

1 reference

12 December 2020

Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation

1 reference

12 December 2020

Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer

1 reference

12 December 2020

Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate

1 reference

12 December 2020

DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications

1 reference

12 December 2020

Flow cytometric DNA analysis of fresh prostatic resections. Correlation with conventional prognostic parameters in patients with prostate cancer

1 reference

12 December 2020

Practical clinical utility of DNA ploidy for managing patients with prostate carcinoma

1 reference

12 December 2020

10.1158/0008-5472.CAN-08-2467

Identifiers

DOI

1 reference

17 October 2017

1 reference

17 October 2017

1 reference